{"altmetric_id":4688686,"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["Merck Sharp & Dohme Corp."],"first_seen_on":"2015-10-28T12:54:26+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1429196400,"links":["https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02251990?term=grazoprevir&rank=11"],"nct_id":"NCT02251990","pubdate":"2014-09-25T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination in Treatment-Na\u00efve Hepatitis C Virus Participants (MK-5172-067)","type":"clinical_trial_study_record"},"altmetric_score":{"score":6.728,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":6.728},"context_for_score":{"all":{"total_number_of_other_articles":5002777,"mean":5.9270417036477,"rank":747368,"this_scored_higher_than_pct":85,"this_scored_higher_than":4255236,"rank_type":"exact","sample_size":5002777,"percentile":85},"similar_age_3m":{"total_number_of_other_articles":188839,"mean":10.043798049121,"rank":38252,"this_scored_higher_than_pct":79,"this_scored_higher_than":150587,"rank_type":"exact","sample_size":188839,"percentile":79},"this_journal":{"total_number_of_other_articles":13165,"mean":4.6125525676086,"rank":2706,"this_scored_higher_than_pct":79,"this_scored_higher_than":10459,"rank_type":"exact","sample_size":13165,"percentile":79},"similar_age_this_journal_3m":{"total_number_of_other_articles":689,"mean":4.9621220930233,"rank":146,"this_scored_higher_than_pct":78,"this_scored_higher_than":543,"rank_type":"exact","sample_size":689,"percentile":78}}},"demographics":[],"counts":{"total":{"posts_count":1},"blogs":{"unique_users_count":1,"unique_users":[52921],"posts_count":1}},"posts":{"blogs":[{"title":"Treating hepatitis C: literature update","url":"http:\/\/theincidentaleconomist.com\/wordpress\/treating-hepatitis-c-literature-update\/","license":"public","citation_ids":[3730732,3320685,3730724,3719851,3795607,3795608,3850756,3059235,2275290,2875467,2875992,4688686],"posted_on":"2015-04-16T15:00:00+00:00","summary":"The following is a guest post by Allan Joseph, a medical student at the Warren Alpert Medical School of Brown University and TIE research assistant. You can follow Allan on Twitter: @allanmjoseph. Links to Allan&rsquo;s previous posts on hepatitis C can be","author":{"name":"The Incidental Economist","url":"http:\/\/theincidentaleconomist.com\/wordpress","description":"Contemplating health care with a focus on research, an eye on reform."}}]}}